Jane Street’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-11,200
| Closed | -$151K | – | 9790 |
|
|
2020
Q4 | $151K | Sell |
11,200
-1,300
| -10% | -$15.7K | ﹤0.01% | 7077 |
|
|
2020
Q3 | $147K | Buy |
+12,500
| New | +$152K | ﹤0.01% | 6609 |
|
|
2020
Q1 | – | Sell |
-48,900
| Closed | -$1.18M | – | 6207 |
|
|
2019
Q4 | $1.18M | Hold |
48,900
| – | – | ﹤0.01% | 2547 |
|
|
2019
Q3 | $940K | Buy |
+48,900
| New | +$1.12M | ﹤0.01% | 2701 |
|
|
2018
Q3 | – | Sell |
-21,700
| Closed | -$1.47M | – | 5897 |
|
|
2018
Q2 | $1.47M | Buy |
+21,700
| New | +$1.21M | ﹤0.01% | 2286 |
|
|
2018
Q1 | – | Sell |
-4,500
| Closed | -$269K | – | 5611 |
|
|
2017
Q4 | $269K | Sell |
4,500
-1,500
| -25% | -$91K | ﹤0.01% | 3890 |
|
|
2017
Q3 | $292K | Buy |
+6,000
| New | +$327K | ﹤0.01% | 3729 |
|
|
2016
Q4 | – | Sell |
-73,700
| Closed | -$2.78M | – | 4778 |
|
|
2016
Q3 | $2.78M | Buy |
+73,700
| New | +$1.63M | 0.01% | 934 |
|
Jane Street's AERI Position: Q4 2022 in Review
Jane Street sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 13,041 shares — an estimated $197K sold.
Jane Street first reported a position in AERI in Q2 2014 and held it in 16 quarters. The position peaked at $1.81M in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Jane Street reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Jane Street sold 13,041 Aerie Pharmaceuticals shares in Q4 2022, an estimated $197K.
- Jane Street first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Jane Street's Aerie Pharmaceuticals position peaked at $1.81M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.